© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
GeneDx Holdings Corp. (WGS) stock surged +1.90%, trading at $75.77 on NASDAQ, up from the previous close of $74.36. The stock opened at $75.16, fluctuating between $75.06 and $81.89 in the recent session.
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Employees | 1000 |
Beta | 2.18 |
Sales or Revenue | $202.57M |
5Y Sales Change% | -0.691% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |
GeneDx Holdings Corp. (NASDAQ: WGS) stock price is $75.77 in the last trading session. During the trading session, WGS stock reached the peak price of $81.89 while $75.06 was the lowest point it dropped to. The percentage change in WGS stock occurred in the recent session was 1.9% while the dollar amount for the price change in WGS stock was $1.41.
The NASDAQ listed WGS is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. GeneDx Holdings Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Murali Mani
Chief Compliance & Privacy Officer
Dr. Ke Hao
Head of Statistical Genomics
Mr. Devin K. Schaffer J.D., M.B.A.
Gen. Counsel
Mr. Jason Ryan
Executive Chair of the Board
Mr. Isaac Ro
Consultant
Dr. Gustavo Stolovitzky Ph.D.
Chief Science Officer
Mr. Kareem M. Saad
Chief Transformation Officer
Dr. Rong Chen Ph.D.
Chief Health Informatics Officer
Mr. Matthew Phillips
Senior Vice President of Bus. Devel.
Dr. Matthew Davis Ph.D.
Chief Technology & Product Officer
Ms. Karen White
Chief People Officer
Ms. Katherine A. Stueland
Pres, Chief Executive Officer & Director
Mr. Kevin Feeley
Senior Vice President of Operations & Chief Financial Officer
WGS's closing price is 2,558.6% higher than its 52-week low of $2.85 where as its distance from 52-week high of $98.87 is -23.36%.
Number of WGS employees currently stands at 1,000.
Official Website of WGS is: http://www.genedx.com
WGS could be contacted at phone 800 298 6470 and can also be accessed through its website. WGS operates from North Tower, Stamford, CT 06902, United States.
WGS stock volume for the day was 747.81K shares. The average number of WGS shares traded daily for last 3 months was 699.07K.
The market value of WGS currently stands at $2.08B with its latest stock price at $75.77 and 27.47M of its shares outstanding.